Influence of the legislation on the advertisement of psychoactive medications in Brazil

Detalhes bibliográficos
Autor(a) principal: Mastroianni, Patrícia de Carvalho [UNIFESP]
Data de Publicação: 2003
Outros Autores: Galduróz, José Carlos Fernandes [UNIFESP], Carlini, Elisaldo Araujo [UNIFESP]
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Institucional da UNIFESP
Texto Completo: http://dx.doi.org/10.1590/S1516-44462003000300006
http://repositorio.unifesp.br/handle/11600/1840
Resumo: OBJECTIVE: The regulations on the advertisement of medications aim to encourage and promote an improved health care and the rational use of medications. The objective of this paper is to evaluate the influence of three regulations on the advertisement of medications: the Export act, published in the United States in 1986; the WHO's Criteria, published in 1988, and the Resolution 102/2000 of the Collegiate Board of Directors of the ANVISA (Agência Nacional de Vigilância Sanitária- Brazilian Sanitary Surveillance Agency), on the advertisement of psychoactive medications. METHOD: We collected advertisements that were published in Brazilian psychiatric journals before and after the regulations were established. The contents of the advertisements were analyzed according to a program created based on the regulation's demands. RESULTS: In the 118 analyzed issues there were 199 different advertisements on 85 psychotropic drugs. We observed that, regardless the studied medication, the information about restrictions of use, such as adverse drug reactions, interactions, contraindications, warnings and precautions, does not appear very often, and when it does, its print sizes were smaller than that of the information favoring the use, such as indication, presentation and dosage. After the publication of the regulations, only 38.2% of the advertisements had all the essential technical information, and 35.3% were irregular in some way. CONCLUSION: The data suggest that there was very little influence of the regulations on the advertisement of psychotropic drugs in Brazil. Consequently, other control measures are necessary in addition to the regulations.
id UFSP_ce8013ad00ff21c3c3463e360cdd9591
oai_identifier_str oai:repositorio.unifesp.br/:11600/1840
network_acronym_str UFSP
network_name_str Repositório Institucional da UNIFESP
repository_id_str 3465
spelling Influence of the legislation on the advertisement of psychoactive medications in BrazilInfluência da legislação sobre as propagandas de medicamentos psicoativos no BrasilAdvertisingLegislation about drugLegislation on medicationPsychotropic drugsPublicidadeLeis sobre medicamentosLegislaçãoPublicidade de medicamentosPsicotrópicosOBJECTIVE: The regulations on the advertisement of medications aim to encourage and promote an improved health care and the rational use of medications. The objective of this paper is to evaluate the influence of three regulations on the advertisement of medications: the Export act, published in the United States in 1986; the WHO's Criteria, published in 1988, and the Resolution 102/2000 of the Collegiate Board of Directors of the ANVISA (Agência Nacional de Vigilância Sanitária- Brazilian Sanitary Surveillance Agency), on the advertisement of psychoactive medications. METHOD: We collected advertisements that were published in Brazilian psychiatric journals before and after the regulations were established. The contents of the advertisements were analyzed according to a program created based on the regulation's demands. RESULTS: In the 118 analyzed issues there were 199 different advertisements on 85 psychotropic drugs. We observed that, regardless the studied medication, the information about restrictions of use, such as adverse drug reactions, interactions, contraindications, warnings and precautions, does not appear very often, and when it does, its print sizes were smaller than that of the information favoring the use, such as indication, presentation and dosage. After the publication of the regulations, only 38.2% of the advertisements had all the essential technical information, and 35.3% were irregular in some way. CONCLUSION: The data suggest that there was very little influence of the regulations on the advertisement of psychotropic drugs in Brazil. Consequently, other control measures are necessary in addition to the regulations.OBJETIVO: Os regulamentos sobre propaganda de medicamentos visam apoiar e fomentar a melhoria da atenção à saúde e o uso racional de medicamentos. O objetivo deste trabalho é avaliar a influência de três regulamentos sobre propaganda de medicamentos: Export act, publicado em 1986 nos Estados Unidos; os Critérios da OMS, em 1988 e a Resolução da Diretoria Colegiada n° 102 de 2000 da ANVISA (Agência Nacional de Vigilância Sanitária), sobre os anúncios de medicamentos psicoativos. MÉTODO: Foram coletados anúncios em periódicos de psiquiatria nacionais, publicados antes e após cada regulamento. O conteúdo dos anúncios foi analisado de acordo com um roteiro de análise de conteúdo elaborado segundo as exigências dos regulamentos. RESULTADOS: Dos 118 fascículos analisados, foram obtidos 199 anúncios diferentes de 85 medicamentos psicoativos. Observou-se que, independentemente do regulamento estudado, as informações que restringem o uso, como reações adversas ao medicamento (RAM), interações, contra-indicações, advertências e precauções estão presentes em menor freqüência e num tamanho de letra menor do que as informações que favorecem o uso, como indicação, apresentação e posologia. Depois de todos os atos publicados apenas 38,2% dos anúncios continham todas as informações técnicas imprescindíveis, e 35,3% dos anúncios apresentavam alguma irregularidade. CONCLUSÃO: Os dados sugerem que houve pouca influência dos regulamentos sobre os anúncios de medicamentos psicoativos no Brasil, portanto, faz-se necessário adotar outras medidas de controle além de regulamentos.Federal University of São Paulo Paulista Medical School Department of PsychobiologyUniversity of São Paulo Paulista Medical School Department of PsychobiologyUNIFESP, EPM, Department of PsychobiologySciELOAssociação Brasileira de Psiquiatria - ABPUniversidade Federal de São Paulo (UNIFESP)University of São Paulo Paulista Medical School Department of PsychobiologyMastroianni, Patrícia de Carvalho [UNIFESP]Galduróz, José Carlos Fernandes [UNIFESP]Carlini, Elisaldo Araujo [UNIFESP]2015-06-14T13:30:07Z2015-06-14T13:30:07Z2003-09-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersion146-155application/pdfhttp://dx.doi.org/10.1590/S1516-44462003000300006Revista Brasileira de Psiquiatria. Associação Brasileira de Psiquiatria - ABP, v. 25, n. 3, p. 146-155, 2003.10.1590/S1516-44462003000300006S1516-44462003000300006.pdf1516-4446S1516-44462003000300006http://repositorio.unifesp.br/handle/11600/1840engRevista Brasileira de Psiquiatriainfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da UNIFESPinstname:Universidade Federal de São Paulo (UNIFESP)instacron:UNIFESP2024-07-30T01:19:19Zoai:repositorio.unifesp.br/:11600/1840Repositório InstitucionalPUBhttp://www.repositorio.unifesp.br/oai/requestbiblioteca.csp@unifesp.bropendoar:34652024-07-30T01:19:19Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP)false
dc.title.none.fl_str_mv Influence of the legislation on the advertisement of psychoactive medications in Brazil
Influência da legislação sobre as propagandas de medicamentos psicoativos no Brasil
title Influence of the legislation on the advertisement of psychoactive medications in Brazil
spellingShingle Influence of the legislation on the advertisement of psychoactive medications in Brazil
Mastroianni, Patrícia de Carvalho [UNIFESP]
Advertising
Legislation about drug
Legislation on medication
Psychotropic drugs
Publicidade
Leis sobre medicamentos
Legislação
Publicidade de medicamentos
Psicotrópicos
title_short Influence of the legislation on the advertisement of psychoactive medications in Brazil
title_full Influence of the legislation on the advertisement of psychoactive medications in Brazil
title_fullStr Influence of the legislation on the advertisement of psychoactive medications in Brazil
title_full_unstemmed Influence of the legislation on the advertisement of psychoactive medications in Brazil
title_sort Influence of the legislation on the advertisement of psychoactive medications in Brazil
author Mastroianni, Patrícia de Carvalho [UNIFESP]
author_facet Mastroianni, Patrícia de Carvalho [UNIFESP]
Galduróz, José Carlos Fernandes [UNIFESP]
Carlini, Elisaldo Araujo [UNIFESP]
author_role author
author2 Galduróz, José Carlos Fernandes [UNIFESP]
Carlini, Elisaldo Araujo [UNIFESP]
author2_role author
author
dc.contributor.none.fl_str_mv Universidade Federal de São Paulo (UNIFESP)
University of São Paulo Paulista Medical School Department of Psychobiology
dc.contributor.author.fl_str_mv Mastroianni, Patrícia de Carvalho [UNIFESP]
Galduróz, José Carlos Fernandes [UNIFESP]
Carlini, Elisaldo Araujo [UNIFESP]
dc.subject.por.fl_str_mv Advertising
Legislation about drug
Legislation on medication
Psychotropic drugs
Publicidade
Leis sobre medicamentos
Legislação
Publicidade de medicamentos
Psicotrópicos
topic Advertising
Legislation about drug
Legislation on medication
Psychotropic drugs
Publicidade
Leis sobre medicamentos
Legislação
Publicidade de medicamentos
Psicotrópicos
description OBJECTIVE: The regulations on the advertisement of medications aim to encourage and promote an improved health care and the rational use of medications. The objective of this paper is to evaluate the influence of three regulations on the advertisement of medications: the Export act, published in the United States in 1986; the WHO's Criteria, published in 1988, and the Resolution 102/2000 of the Collegiate Board of Directors of the ANVISA (Agência Nacional de Vigilância Sanitária- Brazilian Sanitary Surveillance Agency), on the advertisement of psychoactive medications. METHOD: We collected advertisements that were published in Brazilian psychiatric journals before and after the regulations were established. The contents of the advertisements were analyzed according to a program created based on the regulation's demands. RESULTS: In the 118 analyzed issues there were 199 different advertisements on 85 psychotropic drugs. We observed that, regardless the studied medication, the information about restrictions of use, such as adverse drug reactions, interactions, contraindications, warnings and precautions, does not appear very often, and when it does, its print sizes were smaller than that of the information favoring the use, such as indication, presentation and dosage. After the publication of the regulations, only 38.2% of the advertisements had all the essential technical information, and 35.3% were irregular in some way. CONCLUSION: The data suggest that there was very little influence of the regulations on the advertisement of psychotropic drugs in Brazil. Consequently, other control measures are necessary in addition to the regulations.
publishDate 2003
dc.date.none.fl_str_mv 2003-09-01
2015-06-14T13:30:07Z
2015-06-14T13:30:07Z
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://dx.doi.org/10.1590/S1516-44462003000300006
Revista Brasileira de Psiquiatria. Associação Brasileira de Psiquiatria - ABP, v. 25, n. 3, p. 146-155, 2003.
10.1590/S1516-44462003000300006
S1516-44462003000300006.pdf
1516-4446
S1516-44462003000300006
http://repositorio.unifesp.br/handle/11600/1840
url http://dx.doi.org/10.1590/S1516-44462003000300006
http://repositorio.unifesp.br/handle/11600/1840
identifier_str_mv Revista Brasileira de Psiquiatria. Associação Brasileira de Psiquiatria - ABP, v. 25, n. 3, p. 146-155, 2003.
10.1590/S1516-44462003000300006
S1516-44462003000300006.pdf
1516-4446
S1516-44462003000300006
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv Revista Brasileira de Psiquiatria
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv 146-155
application/pdf
dc.publisher.none.fl_str_mv Associação Brasileira de Psiquiatria - ABP
publisher.none.fl_str_mv Associação Brasileira de Psiquiatria - ABP
dc.source.none.fl_str_mv reponame:Repositório Institucional da UNIFESP
instname:Universidade Federal de São Paulo (UNIFESP)
instacron:UNIFESP
instname_str Universidade Federal de São Paulo (UNIFESP)
instacron_str UNIFESP
institution UNIFESP
reponame_str Repositório Institucional da UNIFESP
collection Repositório Institucional da UNIFESP
repository.name.fl_str_mv Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP)
repository.mail.fl_str_mv biblioteca.csp@unifesp.br
_version_ 1814268435653197824